.
Sign in | Register
Home | My Space | Post
 biomagic - Follow | Private Message
539 replies  | 133 followers | 2 following
View profile
Post your View/Query
Replies | Rated | Following | Addressed
Latest
3 days ago
It all depends on the new launches.... even if trastuzumab is launched successfully by dec-end then 1000 is an easy target. buy now below 700... because that is a forgone conclusion in nest 10 days ...
  biomagic
Reposted 3 days ago by jamesbond100
6 days ago
50% cagr to be achieved by biosimilars in international market by 2022 - according to top research firm market growth is primarily driven by the increasing demand for biosimilar drugs due to their ...
  biomagic
     
6 days ago
Cheer up guys, waiting time is to end soon! on 26-apr-2018, dividend will also be announced along with fantastic results.... expect 700 mark in april end!!!...
  biomagic
6 days ago
Although the market expects robust growth through 2022, there are a number of factors impacting the global biosimilars industry. chief among them is patent challenges from the original drug maker. t...
  biomagic
6 days ago
Billions of dollars are at stake for the nded pharmaceuticals market due to patent expiration, said report author and bcc research analyst kamna jhamb. this has led to a strong push for the biosimil...
  biomagic
6 days ago
Merging markets are leading the growth of the biosimilars market, with an estimated cagr of 30.9% through 2022. europe was expected to grow at a cagr of 30.2% through the period, with north america ...
  biomagic
6 days ago
An increase in the aging population, rising incidences of various diseases and increasing pressure to cut healthcare costs are driving explosive growth of the biosimilars market, according to a repo...
  biomagic
6 days ago
Biosimilars market to see 30.5% annual growth through 2022- read the link below: ://globenewswire/news-release/2018/04/16/1471824/0/en/biosimilars-market-to-see-30-5-annual-growth-through-2022.html...
  biomagic
6 days ago
We will continue to engage external consultants, biocon assures usfda ://indianexpress/article/businesspanies/we-will-continue-to-engage-external-consultants-biocon-assures-usfda-5140115/...
  biomagic
6 days ago
Biocon with the power of tpc`s - the international 3rd party consultants is likely to get quick usfda approvals shortly.... the scrip has the otential to more than double in less than 8 months. look...
  biomagic
1 | 2 | 3   Next »
view comment
Stock Boarder Message
Active Topics
Just Posted | index | SpiceJet | Divis Labs | MMTC Ltd
Explore all topics
Boarder of the Day
amateurinvestor (26412 messages | 2207 followers)
HOME
Moneycontrol Home
Font Size: S M L
Customer Support
© 2018 a Web18 Venture